Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: FWIW...here is my summary to try to navigate this USPTO quagmire..

Which brings us back to milestone's question which I would regard as unanswerable with any degree of accuracy at this time

.

how many licenses were signed since this became public knowledge

.

I'm not sure how my question is unanswerable, I'm just not sure when Moore started posting about the disagreement. Was it before or after the SANYO license. Obviously the July/August licensing was subsequent, so it would appear that Alliacense are still able to sign deals for the MMP Portfolio.

.

.

Be well

Share
New Message
Please login to post a reply